The Company's 2022 Annual Shareholder's Meeting approved the removal of the Company's new directors and their representatives from non-competition restrictions

 The Company's 2022 Annual Shareholder's Meeting
approved the removal of the Company's new directors and
their representatives from non-competition restrictions

1.Date of the shareholders meeting resolution:2022/06/21
2.Name and title of the director with permission to engage in competitive
  conduct:
(1)TCI CO., Ltd. institutional director representative:Tsong-Jieh Chiou
(2)Formosa Biomedical Technology Corp.
   institutional director representative: Shih-Ming Lai
3.Items of competitive conduct in which the director is permitted to engage:
 Companies with the same or similar business scope as the Company.
4.Period of permission to engage in the competitive conduct:
 During the term as a director of the Company.
5.Circumstances of the resolution (please describe the results of voting in
accordance with Article 209 of the Company Act):
 Resolution was approved after voting.
6.If the permitted competitive conduct belongs to the operator of a mainland
China area enterprise, the name and title of the directors
(if it is not the operator of a Mainland-area enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China area enterprise and the director's
position in the enterprise:N/A
8.Address of the mainland China area enterprise:N/A
9.Operations of the mainland China area enterprise:N/A
10.Impact on the company's finance and business:N/A
11.If the directors have invested in the mainland China area enterprise,
the monetary amount of the investment and their shareholding ratio:N/A
12.Any other matters that need to be specified:None